Trial Profile
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 29 Jul 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 29 Jul 2008 New trial record.